HSIC vs PRLB · P/E 24, rev $12.67B vs P/E 75, $1.89B cap
Henry Schein Inc (HSIC) versus Proto Labs Inc (PRLB) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
PRLB does not have a complete income-statement cache yet.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. PRLB currently screens at market cap $1.89B and trailing P/E 75.1.
Not investment advice. Open the HSIC and PRLB stock pages for the full models.
Not investment advice.